Skip to main content
Premium Trial:

Request an Annual Quote

Affy Names Sysmex New Japanese Distributor, Says Firm Can Develop IVDs Based on GeneChips

This update clarifies that Sysmex will distribute Affy's diagnostic arrays, not the GeneChip research arrays.
NEW YORK (GenomeWeb News) — Affymetrix has hired Japanese lab diagnostics company Sysmex to sell its GeneChip diagnostic arrays and instruments in Japan, and has enabled the company to develop and market its own in vitro diagnostics based on the GeneChip platform.
The deal gives Sysmex exclusive rights to distribute the diagnostic arrays and instruments in Japan, and could enable it to distribute the products to other countries in Southeast Asia.
Another part of the agreement gives Sysmex non-exclusive rights to use the GeneChip to develop and market its in vitro tests worldwide.
The company currently has tests in the areas of urinalysis, immunochemistry, hematology, and hemostasis, and is now marketing a test to detect lymph node metastases in breast cancer patients.
Financial terms of the agreements were not released.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.